$0.4045
-0.0236-5.51%
Last update: Oct 23, 7:54 PM
EyePoint Inc (EYPT) Stock Price, Quote, News & History
EYPTNASDAQ
EyePoint cuts 53% of staff and halts wet AMD trials after DURAVYU misses its Phase 3 primary endpoint, pivoting its focus entirely to DME.
You can purchase shares of EyePoint (NASDAQ:EYPT) through any online brokerage.
Other companies in EyePoint’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
EyePoint has a consensus price target of $23.33.
The stock price for EyePoint (NASDAQ: EYPT) is $0.415 last updated October 23, 2026 at 7:54 PM EDT.
There are no upcoming dividends for EyePoint.
EyePoint does not have any upcoming earnings scheduled.
There is no upcoming split for EyePoint.
EyePoint is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's...
